European Opportunities Trust (EOT) Reports June 2026 Portfolio: Infineon and Novo Nordisk Dominate £447m Assets

European Opportunities Trust's Net Assets Total £447m at June 2026 Close

As of 30 June 2026, European Opportunities Trust PLC reported total net assets amounting to £447,299,137. The statement confirms that total assets, inclusive of any drawdown bank debt, equal the same amount, indicating the trust held no net drawn-down debt at the end of June. This aligns with the disclosed positive cash or gearing position of 2.0%, reflecting a modest net cash holding rather than leverage on that date.

The £447m asset base establishes European Opportunities Trust as a significant player within the London-listed investment trust sector focused on continental and broader European equities. The trust provides monthly portfolio updates via RNS and its website at www.europeanopportunitiestrust.com, offering transparency into portfolio construction. No comparative figures from previous months were included in this announcement.

Infineon Technologies Tops Holdings at 7.7% of Portfolio

Infineon Technologies, a German semiconductor company classified under information technology, represents the largest portfolio weighting at 7.7% as of 30 June 2026. This reflects the trust manager Devon Equity Management Limited’s conviction in European chipmakers amid sustained global demand for power semiconductors, automotive electronics, and industrial chips.

Following Infineon, Danish pharmaceutical firm Novo Nordisk holds 7.5% of total assets. Known for its leadership in obesity and diabetes treatments, Novo Nordisk is a key healthcare holding. Together, these two stocks comprise 15.2% of the portfolio, a concentration investors should watch closely. The update does not provide commentary on changes in these positions since the prior month.

Healthcare and Industrials Dominate Sector Exposure

Sector analysis of the top twenty holdings shows a pronounced emphasis on healthcare and industrials. Healthcare companies include Novo Nordisk (7.5%), Genus Plc (6.5%), Camurus (6.2%), Grifols (4.5%), and BioMérieux (3.1%), covering diverse areas such as therapeutics, animal genetics, and diagnostics.

Industrials feature prominently as well, with holdings like Experian Plc (6.5%), Relx Plc (5.2%), Prysmian (3.4%), BAE Systems Plc (2.8%), Ryanair Holdings ADRs (2.8%), VAT Group (2.4%), and Thales (2.2%). This sector spans data analytics, defence, aviation, and cable manufacturing, illustrating broad industrial exposure across European markets. Together, healthcare and industrials dominate the trust’s top twenty holdings.

France Is the Largest Geographic Allocation at 22.4%

France represents the largest country allocation within the portfolio at 22.4% as of 30 June 2026. French-listed top holdings include Dassault Systèmes (5.3%), Gaztransport Et Technigaz (4.8%), Edenred (4.3%), BioMérieux (3.1%), and Thales (2.2%), spanning software, LNG containment, payment services, diagnostics, and defence electronics sectors.

The United Kingdom follows with 17.6% of assets, represented by Genus Plc (6.5%), ICG Plc (5.8%), BAE Systems Plc (2.8%), and Wise Plc (2.6%). Germany ranks third at 16.3%, with Infineon Technologies (7.7%), Deutsche Boerse (6.3%), and CTS Eventim (2.3%) as key holdings. Ireland (9.2%), Denmark (8.3%), and Sweden (6.9%) complete the next tier, with smaller allocations to the Netherlands, Spain, Italy, and Switzerland. Cash and gearing make up the remaining 2.0%.

Financial Sector Anchored by Deutsche Boerse and ICG

Within financials, Deutsche Boerse accounts for 6.3% of total assets, representing a leading German exchange and market infrastructure operator. UK-based alternative asset manager ICG Plc holds 5.8%, while French employee benefits company Edenred contributes 4.3%, and UK fintech Wise Plc adds 2.6%. Combined, these four companies represent about 19.0% of the top twenty holdings, forming a significant portion of the financial sector exposure.

This diversified financial sector exposure spans exchange infrastructure, alternative credit management, corporate benefits, and retail fintech, with no conventional European commercial banks included among the top holdings. The announcement does not discuss portfolio strategy or sector positioning rationale.

Large-Cap Stocks Constitute 83.4% of Portfolio

The update confirms that large-cap stocks make up 83.4% of total assets as of 30 June 2026, while mid-cap holdings represent 14.1%, and small-cap exposure is minimal at 0.5%. The remaining 2.0% corresponds to cash or gearing. This large-cap focus is consistent with the portfolio’s foundation in established European companies such as Infineon, Novo Nordisk, Experian, Deutsche Boerse, and BAE Systems.

The small-cap allocation’s low level suggests limited exposure to earlier-stage or less liquid European firms at this time. Mid-cap exposure provides some growth potential beyond the large-cap core. No information was provided on changes to these market cap weightings compared to previous months.

Camurus and Grifols Highlight Swedish and Spanish Healthcare Positions

Within healthcare, Camurus, a Swedish specialty pharmaceutical company, is the sixth-largest holding at 6.2%, reflecting strong conviction from Devon Equity Management. Camurus focuses on long-acting drug formulations for addiction and endocrine disorders, ranking ahead of several blue-chip European stocks in the portfolio.

Grifols, a Spanish plasma-derived protein therapeutics company, accounts for 4.5% of total assets and represents the trust’s sole exposure to the Iberian Peninsula. Spain’s total country allocation is 4.5%, meaning Grifols constitutes the entire Spanish weighting, marking a notable concentration for geographic and company-specific risk assessment.

Gaztransport Et Technigaz Is the Trust’s Only Energy Holding

Gaztransport Et Technigaz (GTT), a French engineering firm specializing in membrane containment systems for liquefied natural gas carriers, is the trust’s only energy sector holding among the top twenty, weighted at 4.8%. Listed in France, GTT contributes to the country’s 22.4% allocation and reflects a selective approach to energy exposure focused on LNG infrastructure rather than broad energy sector investments.

GTT’s business centers on cryogenic membrane systems for LNG tankers and floating storage units, benefiting from strong global LNG demand. The update provides no commentary on the investment thesis or position changes for GTT; further details can be found in the trust’s latest reports at www.europeanopportunitiestrust.com.

Devon Equity Management Manages the Portfolio; Contact Richard Pavry for Inquiries

Devon Equity Management Limited serves as the investment manager for European Opportunities Trust. Inquiries related to the announcement should be directed to Richard Pavry at Devon Equity Management, with contact details provided in the release. The manager is responsible for portfolio decisions reflected in the monthly disclosures.

The company’s legal entity identifier is 549300XN7RXQWHN18849. The announcement, dated 2 July 2026, covers portfolio positions as of 30 June 2026. No immediate share price impact was evident at the time of publication.

Key Considerations for EOT Investors Moving Forward

Given the portfolio’s concentration in large-cap European equities across healthcare, industrials, financials, and information technology, investors should closely monitor macroeconomic trends in France, Germany, and the UK, which collectively represent over 56% of assets. Changes in European economic conditions, European Central Bank interest rate policy, or sector-specific regulations affecting healthcare or technology could significantly influence portfolio value.

With Infineon Technologies and Novo Nordisk each exceeding 7% weightings, company-specific developments could notably impact net asset value. Investors should also observe any shifts in the trust’s 2.0% net cash position in future monthly updates, as movements toward gearing or increased cash holdings may signal changing market outlooks by the manager. The forthcoming portfolio update will provide the next insight into any portfolio adjustments by Devon Equity Management.